Phytomedicine is a peer-reviewed medical journal published by Elsevier that focuses on phytotherapy and pharmacological evidence of plant-derived medicines with a 2025 impact factor of 11.3.《植物医学》（Phytomedicine）是由爱思唯尔（Elsevier）出版的同行评审医学期刊，聚焦植物疗法及植物源药物的药理学证据，2025年影响因子为11.3
*It is primarily a therapy-oriented journal publishing innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts and phytopharmaceuticals.该刊以治疗为导向，发表关于特定植物提取物和植物药物的功效、安全性、质量及作用机制的创新研究
*Coverage includes clinical, pharmacological, pharmacokinetic and toxicological studies of herbal medicinal products and purified compounds with defined and consistent quality.涵盖草药制剂及纯化化合物的临床、药理学、药代动力学和毒理学研究，要求质量确定且一致
*Ethnopharmacology, traditional medicine evidence and natural-product-based drug discovery are within scope.民族药理学、传统医学证据及天然产物药物发现均在收录范围内
*The journal is published in affiliation with the European Scientific Cooperation on Phytotherapy.该刊与欧洲植物疗法科学合作组织（ESCOP）合作出版
*Its open-access companion title Phytomedicine Plus broadens coverage to integrative and complementary medicine.其开放获取姊妹刊（Phytomedicine Plus）将覆盖范围拓展至综合与补充医学
*Manuscripts must demonstrate reproducible pharmacological activity and adhere to internationally accepted scientific standards.来稿须证明可重复的药理活性并遵循国际通行科学标准
*Founded in 1994 by Hildebert Wagner and Norman Farnsworth to establish international standards for phytomedicine research.1994年由（Hildebert Wagner）与（Norman Farnsworth）创办，旨在为植物药物研究制定国际标准
*Originally published by Urban and Fischer Verlag in Jena, Germany.最初由德国耶拿的（Urban and Fischer Verlag）出版
*Elsevier acquired the Urban and Fischer imprint and assumed publication of the journal.爱思唯尔收购（Urban and Fischer）品牌并承接该刊出版
*Thomas Efferth became editor-in-chief in 2017 and the journal grew from bimonthly to over 1000 articles per year.2017年（Thomas Efferth）出任主编，该刊从双月刊发展为年发文量超千篇
*The companion open-access journal Phytomedicine Plus was launched in 2020 under the same editorial leadership.姊妹开放获取刊（Phytomedicine Plus）于2020年创刊，主编团队相同
*The current editor-in-chief is Thomas Efferth, professor of pharmaceutical biology at Johannes Gutenberg University Mainz.现任主编为（Thomas Efferth），美因茨大学（Johannes Gutenberg University Mainz）药物生物学教授
*Founding editor Hildebert Wagner served until his death in 2021 and retains an honorary editorial role.创刊主编（Hildebert Wagner）任职至2021年去世，保留名誉主编身份
*The editorial board includes scholars from Argentina, Turkey, China and other countries specializing in phytochemistry and pharmacology.编委会涵盖阿根廷、土耳其、中国等多国学者，专长为植物化学与药理学
*Submissions are managed through Editorial Manager with double-blind peer review.来稿通过（Editorial Manager）系统处理，实行双盲同行评审
*Section editors handle specialized topics such as clinical trials, ethnopharmacology, toxicology and quality control.分区编辑分别负责临床试验、民族药理学、毒理学和质量控制等专题